India as an underdog never had an edge of first-mover, particularly in bio-technological and mechanical arena. But with the aid of tie ups and mergers with olfactory multinationals, Indian Pharmaceutical Companies are benefited with the advanced R&D facilities and innovations. Technology is being taken to the new dimension of automation wherein human efforts are only directed and focused on strategically developing the series of activities like distribution system, marketing, and selling. After lot of innovations and research, professionals have come up with the automated machines in the pharma sector. And thus, India has evolved as a key player in exporting sophisticated food and pharma processing machines. To name some, machines like Sheer mixture can mix different powders uniformly or in the pre-described ratio an pellet machine is accoutred with function of rotatable matrix, adjustable pressing rollers etc. These machines are generic in nature and its functionality has been tested across the variety of product and climatic conditions.
These exporters handle the distribution of machines, from the production facility to the door of the buyer. This exporting industry will bridge the gap between demand and supply which is apparent in untapped market of underdeveloped Asian and Middle East countries. India should invest more in R&D and infrastructure doing away with its deficiency to come up with advanced machines and manufacture such machines domestically.
Bio-technology has lot of potential and opportunities to discover, exploit, and capitalize. India is gradually moving from the service provider country to the end-to-end solution provider and this sector will nudge the pharmaceutical industry standing at 4th rank to higher rank.
These exporters handle the distribution of machines, from the production facility to the door of the buyer. This exporting industry will bridge the gap between demand and supply which is apparent in untapped market of underdeveloped Asian and Middle East countries. India should invest more in R&D and infrastructure doing away with its deficiency to come up with advanced machines and manufacture such machines domestically.
Bio-technology has lot of potential and opportunities to discover, exploit, and capitalize. India is gradually moving from the service provider country to the end-to-end solution provider and this sector will nudge the pharmaceutical industry standing at 4th rank to higher rank.
